18-10763009-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001378183.1(PIEZO2):c.3036A>G(p.Thr1012Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.803 in 1,537,182 control chromosomes in the GnomAD database, including 496,371 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.83 ( 52906 hom., cov: 35)
Exomes 𝑓: 0.80 ( 443465 hom. )
Consequence
PIEZO2
NM_001378183.1 synonymous
NM_001378183.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.382
Publications
19 publications found
Genes affected
PIEZO2 (HGNC:26270): (piezo type mechanosensitive ion channel component 2) The protein encoded by this gene contains more than thirty transmembrane domains and likely functions as part of mechanically-activated (MA) cation channels. These channels serve to connect mechanical forces to biological signals. The encoded protein quickly adapts MA currents in somatosensory neurons. Defects in this gene are a cause of type 5 distal arthrogryposis. Several alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. [provided by RefSeq, Feb 2014]
PIEZO2 Gene-Disease associations (from GenCC):
- Gordon syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
- arthrogryposis, distal, with impaired proprioception and touchInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Illumina, Ambry Genetics
- arthrogryposis- oculomotor limitation-electroretinal anomalies syndromeInheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
- connective tissue disorderInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- Marden-Walker syndromeInheritance: AR, AD Classification: MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 18-10763009-T-C is Benign according to our data. Variant chr18-10763009-T-C is described in ClinVar as Benign. ClinVar VariationId is 261504.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.382 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.925 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PIEZO2 | NM_001378183.1 | c.3036A>G | p.Thr1012Thr | synonymous_variant | Exon 22 of 56 | ENST00000674853.1 | NP_001365112.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PIEZO2 | ENST00000674853.1 | c.3036A>G | p.Thr1012Thr | synonymous_variant | Exon 22 of 56 | NM_001378183.1 | ENSP00000501957.1 |
Frequencies
GnomAD3 genomes AF: 0.830 AC: 126324AN: 152176Hom.: 52852 Cov.: 35 show subpopulations
GnomAD3 genomes
AF:
AC:
126324
AN:
152176
Hom.:
Cov.:
35
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.795 AC: 114981AN: 144596 AF XY: 0.794 show subpopulations
GnomAD2 exomes
AF:
AC:
114981
AN:
144596
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.799 AC: 1107155AN: 1384888Hom.: 443465 Cov.: 59 AF XY: 0.798 AC XY: 545284AN XY: 683362 show subpopulations
GnomAD4 exome
AF:
AC:
1107155
AN:
1384888
Hom.:
Cov.:
59
AF XY:
AC XY:
545284
AN XY:
683362
show subpopulations
African (AFR)
AF:
AC:
29541
AN:
31592
American (AMR)
AF:
AC:
25962
AN:
35700
Ashkenazi Jewish (ASJ)
AF:
AC:
21096
AN:
25180
East Asian (EAS)
AF:
AC:
32242
AN:
35734
South Asian (SAS)
AF:
AC:
60601
AN:
79226
European-Finnish (FIN)
AF:
AC:
27156
AN:
35014
Middle Eastern (MID)
AF:
AC:
4737
AN:
5696
European-Non Finnish (NFE)
AF:
AC:
858758
AN:
1078822
Other (OTH)
AF:
AC:
47062
AN:
57924
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
12534
25068
37602
50136
62670
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20434
40868
61302
81736
102170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.830 AC: 126438AN: 152294Hom.: 52906 Cov.: 35 AF XY: 0.829 AC XY: 61752AN XY: 74456 show subpopulations
GnomAD4 genome
AF:
AC:
126438
AN:
152294
Hom.:
Cov.:
35
AF XY:
AC XY:
61752
AN XY:
74456
show subpopulations
African (AFR)
AF:
AC:
38787
AN:
41580
American (AMR)
AF:
AC:
11596
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
2939
AN:
3472
East Asian (EAS)
AF:
AC:
4733
AN:
5182
South Asian (SAS)
AF:
AC:
3694
AN:
4832
European-Finnish (FIN)
AF:
AC:
8349
AN:
10584
Middle Eastern (MID)
AF:
AC:
252
AN:
294
European-Non Finnish (NFE)
AF:
AC:
53703
AN:
68028
Other (OTH)
AF:
AC:
1739
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1095
2191
3286
4382
5477
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
884
1768
2652
3536
4420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3038
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Gordon syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Marden-Walker syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Arthrogryposis, distal, with impaired proprioception and touch Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.